Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Memantine and cognitive dysfunction in bipolar disorder

Trial Profile

Memantine and cognitive dysfunction in bipolar disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs Memantine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Mar 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Actual end date Jun 2010 added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top